New leader will leverage 25+ years of executive leadership to scale Reveam to its next stage of growth and full commercial operations.
(Atlanta) – Reveam is delighted to announce the appointment of Jeff Pelletier as our new CEO. Mr. Pelletier brings more than 25 years of experience including C-Suite executive positions.
Prior to being named CEO of Reveam, Mr. Pelletier served as the organization’s CTO for the past three years. He will be responsible for driving corporate revenue and market share growth while fostering innovation and upholding our commitment to delivering outstanding services to our customers.
Mr. Pelletier’s previous leadership positions in engineering and technology sectors delivered numerous complex, software controlled electromechanical devices from concept through commercialization. Prior to joining Reveam, Mr. Pelletier served as Vice President of Research & Development for ProNova Solutions, a best-in-class proton therapy system for cancer treatment. In this position, Pelletier was responsible for design, development and launch of a next-generation superconducting proton therapy system from concept to commercial launch.
In addition to his proton therapy experiences, Pelletier previously held leadership positions at GE Healthcare and Hospira, where he held various senior roles responsible for program management, product development and engineering for market leading medical devices and systems including infusion pumps, diagnostic imaging systems and healthcare IT software systems.
Mr. Pelletier, who will be based in Atlanta, holds a Bachelor’s and Master’s degree in Electrical Engineering with a focus on electronics and software development, and a Master of Business Administration from the Kellogg School of Management, Northwestern University.
Mr. Pelletier’s experience in leading advanced technology organizations will position Reveam to take advantage of future opportunities and accelerate its growth as it expands within and beyond its first commercial facility to scale its operations.
Mr. Pelletier assumes the CEO role effective immediately.